OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ETNB

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

89bio (ETNB) Earnings Date & Reports

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ETNB is expected to report earnings to fall 29.80% to -49 cents per share on November 06

Q3'25

Est.

$-0.50

Q2'25

Missed

by $0.21

Q1'25

Beat

by $0.03

Q4'24

Missed

by $0.27

Q3'24

Missed

by $0.77

The last earnings report on August 07 showed earnings per share of -70 cents, missing the estimate of -50 cents. With 855.56K shares outstanding, the current market capitalization sits at 1.39B.

View a ticker or compare two or three

Compare

ETNB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ETNB
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ETNB showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

142 Sansome Street

Phone

+1 415 432-9270

Employees

Web

https://www.89bio.com